Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Unal Atas, Hasan Sozel, Utku Iltar, Orhan Kemal Yucel, Ozan Salim & Levent Undar. (2023) The Prognostic Impact of Pretreatment Geriatric Nutritional Risk Index in Patients with Diffuse Large B-Cell Lymphoma. Nutrition and Cancer 75:2, pages 591-598.
Read now
Read now
Hui-Ling Sun, Yu-Qin Pan, Bang-Shun He, Zhen-Lin Nie, Kang Lin, Hong-Xin Peng, William C Cho & Shu-Kui Wang. (2016) Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports. OncoTargets and Therapy 9, pages 3017-3023.
Read now
Read now
Rachel E. Hayden, Racha Kussaibati, Laura M. Cronin, Guy Pratt, Claudia Roberts, Mark T. Drayson & Christopher M. Bunce. (2015) Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomas. Leukemia & Lymphoma 56:4, pages 1079-1087.
Read now
Read now
Luis F. Porrata, Kay M. Ristow, Thomas M. Habermann, Thomas E. Witzig, Joseph P. Colgan, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Grzegorz Nowakowski, Carrie A. Thompson & Svetomir N. Markovic. (2014) Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:12, pages 2728-2738.
Read now
Read now
Articles from other publishers (23)
Rune Matthiesen, Paula Gameiro, Andreia Henriques, Cristian Bodo, Maria Carolina Strano Moraes, Bruno Costa-Silva, José Cabeçadas, Maria Gomes da Silva, Hans Christian Beck & Ana Sofia Carvalho. (2022) Extracellular Vesicles in Diffuse Large B Cell Lymphoma: Characterization and Diagnostic Potential. International Journal of Molecular Sciences 23:21, pages 13327.
Crossref
Crossref
Mehmet Bakirtas, Semih Basci, BurcuAslan Candır, BaharUncu Ulu, Samet Yaman, TuğçeNur Yiğenoğlu, MehmetSinan Dal, MerihKızıl Çakar & Fevzi Altuntaş. (2022) Prognostic value of neutrophil/lymphocyte ratio, lymphocyte/monocyte ratio, lactate dehydrogenase, and mean platelet volume in the diagnosis of patients with diffuse large B-cell lymphoma. The Egyptian Journal of Haematology 47:4, pages 233.
Crossref
Crossref
Ana Sofia Carvalho, Henrique Baeta, Andreia F. A. Henriques, Mostafa Ejtehadifar, Erin M. Tranfield, Ana Laura Sousa, Ana Farinho, Bruno Costa Silva, José Cabeçadas, Paula Gameiro, Maria Gomes da Silva, Hans Christian Beck & Rune Matthiesen. (2021) Proteomic Landscape of Extracellular Vesicles for Diffuse Large B-Cell Lymphoma Subtyping. International Journal of Molecular Sciences 22:20, pages 11004.
Crossref
Crossref
Pei-Hsuan Chen, Mikel Lipschitz, Jason L. Weirather, Caron Jacobson, Philippe Armand, Kyle Wright, F. Stephen Hodi, Zachary J. Roberts, Stuart A. Sievers, John Rossi, Adrian Bot, William Go & Scott J. Rodig. (2020) Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy. JCI Insight 5:12.
Crossref
Crossref
Tong-Yun Liu, Pei-Zhu Zhao, Hong-Yun Zhang, Hai-Yan Min, Yu-Ye Li, Run-Xiang Yang, Jue Qi, Xiao-Dan Wang, Yan Wu, Li-Hao Chen & Wei Zhang. 2020. Mucocutaneous Manifestations of HIV/AIDS. Mucocutaneous Manifestations of HIV/AIDS
131
186
.
Yan-Li Li, Zhi-Hu Shi, Xian Wang, Kang-Sheng Gu & Zhi-min Zhai. (2018) Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma. Annals of Hematology 98:2, pages 413-422.
Crossref
Crossref
Siqian Wang, Yongyong Ma, Lan Sun, Yifen Shi, Songfu Jiang, Kang Yu & Shujuan Zhou. (2018) Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma. BioMed Research International 2018, pages 1-8.
Crossref
Crossref
Shujuan Zhou, Yongyong Ma, Yifen Shi, Liyuan Tang, Zhouyi Zheng, Fang Fang, Jianhua Feng, Yu Zhang, Lan Sun, Yi Chen, Bin Liang, Songfu Jiang, Zhijian Shen, Kang Yu & Siqian Wang. (2018) Mean platelet volume predicts prognosis in patients with diffuse large B-cell lymphoma. Hematological Oncology 36:1, pages 104-109.
Crossref
Crossref
Aleksander Skulimowski, Piotr Hogendorf, Grażyna Poznańska, Piotr Smolewski, Janusz Strzelczyk & Adam Durczynski. (2017) Successful hemihepatectomy following chemotherapy for primary liver lymphoma: case report and review of literature. Polish Journal of Surgery 89:5, pages 54-58.
Crossref
Crossref
Xiao Han, Jing Ruan, Wei Zhang, Daobin Zhou, Dongsheng Xu, Qiang Pei, Mingqi Ouyang & Mengxuan Zuo. (2017) Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma. Oncotarget 8:29, pages 47790-47800.
Crossref
Crossref
Shujuan Zhou, Fang Fang, Huiyao Chen, Wei Zhang, Yang Chen, Yifen Shi, Zhouyi Zheng, Yongyong Ma, Liyuan Tang, Jianhua Feng, Yu Zhang, Lan Sun, Yi Chen, Bin Liang, Kang Yu & Songfu Jiang. (2017) Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients. Oncotarget 8:25, pages 40724-40731.
Crossref
Crossref
Rui Gao, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Wei Wu, Jia-Zhu Wu, Yi Xia, Lei Cao, Lei Fan, Tao Yang, Jian-Yong Li & Wei Xu. (2017) Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma. British Journal of Haematology 177:1, pages 95-105.
Crossref
Crossref
Shujuan Zhou, Linglong Xu, Yongyong Ma, Liyuan Tang, Yu Zhang, Yifen Shi, Lan Sun, Yi Chen, Bin Liang, Yuhong Zhou, Kang Yu & Jianping Shen. (2017) Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma. Oncotarget 8:12, pages 19556-19565.
Crossref
Crossref
Wen‐Kai Xia, Qing‐Feng Lin, Dong Shen, Zhi‐Li Liu, Jun Su & Wei‐Dong Mao. (2016) Prognostic significance of lymphocyte‐to‐monocyte ratio in diffuse large B‐cell lymphoma: a systematic review and meta‐analysis. FEBS Open Bio 6:6, pages 558-565.
Crossref
Crossref
Benedikt Jacobs, Sara Tognarelli, Kerstin Poller, Peter Bader, Andreas Mackensen & Evelyn Ullrich. (2015) NK Cell Subgroups, Phenotype, and Functions After Autologous Stem Cell Transplantation. Frontiers in Immunology 6.
Crossref
Crossref
José Carlos Jaime-Pérez, Carmen Magdalena Gamboa-Alonso, Alberto Vázquez-Mellado de Larracoechea, Marisol Rodríguez-Martínez, César Homero Gutiérrez-Aguirre, Luis Javier Marfil-Rivera & David Gómez-Almaguer. (2015) Non-Hodgkin Lymphomas: Impact of Rituximab on Overall Survival of Patients with Diffuse Large B-Cell and Follicular Lymphoma. Archives of Medical Research 46:6, pages 454-461.
Crossref
Crossref
Agustin AvilèsMaria-Jesùs NamboJudith Huerta-GuzmànLuis SilvaNatividad Neri. (2015) Rituximab as Consolidation Therapy Did Not Improve Outcome in Patients with Diffuse Large B-Cell Lymphoma at Complete Response After Dose-Dense Chemotherapy (CHOP-14). Cancer Biotherapy and Radiopharmaceuticals 30:3, pages 107-110.
Crossref
Crossref
Angelo Belotti, Elisa Doni, Silvia Bolis, Fausto Rossini, Ivana Casaroli, Sara Pezzatti, Enrico Maria Pogliani & Pietro Enrico Pioltelli. (2015) Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era. Clinical Lymphoma Myeloma and Leukemia 15:4, pages 208-213.
Crossref
Crossref
Yan-Li Li, Kang-Sheng Gu, Yue-Yin Pan, Yang Jiao & Zhi-Min Zhai. (2014) Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. BMC Cancer 14:1.
Crossref
Crossref
Young Wha Koh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh. (2014) Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients?. European Journal of Haematology 93:4, pages 340-348.
Crossref
Crossref
Yan-Li Li, Yue-Yin Pan, Yang Jiao, Jie Ning, Yin-Guang Fan & Zhi-Min Zhai. (2013) Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens. Annals of Hematology 93:4, pages 617-626.
Crossref
Crossref
Jeffrey L. Vacirca, Peter. I. Acs, Imad A. Tabbara, Peter. J. Rosen, Peter Lee & Eric Lynam. (2013) Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma. Annals of Hematology 93:3, pages 403-409.
Crossref
Crossref
Octavian Bucur, Andreea Lucia Stancu, Ioana Goganau, Stefana Maria Petrescu, Bodvael Pennarun, Thierry Bertomeu, Rajan Dewar & Roya Khosravi-Far. (2013) Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells. PLoS ONE 8:10, pages e77390.
Crossref
Crossref